Skip to main content
Erschienen in: Acta Neuropathologica 2/2004

01.08.2004 | Regular Paper

Inferior olivary hypertrophy is uncommon in progressive supranuclear palsy

verfasst von: Omi Katsuse, Dennis W. Dickson

Erschienen in: Acta Neuropathologica | Ausgabe 2/2004

Einloggen, um Zugang zu erhalten

Abstract

Inferior olivary hypertrophy (IOH) is an uncommon disorder attributed to transsynaptic degeneration and characterized clinically by palatal myoclonus and histopathologically by swollen, fenestrated neurons and bizarre astrocytic gliosis. IOH is usually associated with the interruption of the dentato-olivary tract, most often from cerebrovascular lesions in the dentate nucleus or red nucleus. In progressive supranuclear palsy (PSP), the dentato-olivary tract is consistently affected, and there are reports suggesting that IOH may be relatively common in PSP. To address this issue, the frequency of IOH was investigated in 264 PSP brains. To determine if there was a relationship between IOH and neurofibrillary degeneration in the dentato-olivary pathway, the severity of neurofibrillary degeneration was assessed in the inferior olivary nucleus, cerebellar dentate nucleus and red nucleus in PSP cases with and without IOH. IOH was uncommon in PSP, being found in only 4 of 264 (1.5%) brains, which was not significantly different from the frequency in non-PSP controls (8 of 862; 0.9%). In all non-PSP cases IOH was associated with cerebrovascular lesions, but not in any of the PSP cases with IOH. The severity of neurofibrillary degeneration in the inferior olivary nucleus was significantly greater in PSP cases with IOH than in PSP cases without IOH, whereas there were no significant differences in the cerebellar dentate nucleus and red nucleus. These findings suggest that direct neurofibrillary degeneration in the inferior olivary nucleus may be related to IOH in PSP rather than transsynaptic degeneration.
Literatur
1.
Zurück zum Zitat Boesten AJ, Voogd J (1985) Hypertrophy of neurons in the inferior olive after cerebellar ablations in the cat. Neurosci Lett 61:49–54CrossRefPubMed Boesten AJ, Voogd J (1985) Hypertrophy of neurons in the inferior olive after cerebellar ablations in the cat. Neurosci Lett 61:49–54CrossRefPubMed
2.
Zurück zum Zitat Bower JH, Maraganore DM, McDonnell SK, Rocca WA (1997) Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976-1990. Neurology 49:1284–1288PubMed Bower JH, Maraganore DM, McDonnell SK, Rocca WA (1997) Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976-1990. Neurology 49:1284–1288PubMed
3.
Zurück zum Zitat Cowan WM (1970) Anterograde and retrograde transneuronal degeneration in the central and peripheral nervous system. In: Nauta WJH, Ebbeson SOE (eds) Contemporary research methods in neuroanatomy. Springer, New York, Berlin Heidelberg, pp 217–251 Cowan WM (1970) Anterograde and retrograde transneuronal degeneration in the central and peripheral nervous system. In: Nauta WJH, Ebbeson SOE (eds) Contemporary research methods in neuroanatomy. Springer, New York, Berlin Heidelberg, pp 217–251
4.
Zurück zum Zitat Deuschl G, Wilms H (2002) Clinical spectrum and physiology of palatal tremor. Mov Disord 17:S63–66CrossRef Deuschl G, Wilms H (2002) Clinical spectrum and physiology of palatal tremor. Mov Disord 17:S63–66CrossRef
5.
Zurück zum Zitat Deuschl G, Toro C, Valls-Sole J, Zeffiro T, Zee DS, Hallett M (1994) Symptomatic and essential palatal tremor. 1. Clinical, physiological and MRI analysis. Brain 117:775–788PubMed Deuschl G, Toro C, Valls-Sole J, Zeffiro T, Zee DS, Hallett M (1994) Symptomatic and essential palatal tremor. 1. Clinical, physiological and MRI analysis. Brain 117:775–788PubMed
6.
Zurück zum Zitat Dickson DW (1997) Neurodegenerative diseases with cytoskeletal pathology: a biochemical classification. Ann Neurol 42:541–544 Dickson DW (1997) Neurodegenerative diseases with cytoskeletal pathology: a biochemical classification. Ann Neurol 42:541–544
7.
Zurück zum Zitat Dickson DW (1999) Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol 246:6–15CrossRefPubMed Dickson DW (1999) Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol 246:6–15CrossRefPubMed
8.
Zurück zum Zitat Dickson DW, Yen SH, Suzuki KI, Davies P, Garcia JH, Hirano A (1986) Ballooned neurons in select neurodegenerative diseases contain phosphorylated neurofilament epitopes. Acta Neuropathol 71:216–223PubMed Dickson DW, Yen SH, Suzuki KI, Davies P, Garcia JH, Hirano A (1986) Ballooned neurons in select neurodegenerative diseases contain phosphorylated neurofilament epitopes. Acta Neuropathol 71:216–223PubMed
9.
Zurück zum Zitat Giaccone G, Tagliavini F, Street JS, Ghetti B, Bugiani O (1988) Progressive supranuclear palsy with hypertrophy of the olives. An immunocytochemical study of the cytoskeleton of argyrophilic neurons. Acta Neuropathol 77:14–20PubMed Giaccone G, Tagliavini F, Street JS, Ghetti B, Bugiani O (1988) Progressive supranuclear palsy with hypertrophy of the olives. An immunocytochemical study of the cytoskeleton of argyrophilic neurons. Acta Neuropathol 77:14–20PubMed
10.
Zurück zum Zitat Hanihara T, Amano N, Takahashi T, Itoh Y, Yagishita S (1998) Hypertrophy of the inferior olivary nucleus in patients with progressive supranuclear palsy. Eur Neurol 39:97–102CrossRefPubMed Hanihara T, Amano N, Takahashi T, Itoh Y, Yagishita S (1998) Hypertrophy of the inferior olivary nucleus in patients with progressive supranuclear palsy. Eur Neurol 39:97–102CrossRefPubMed
11.
Zurück zum Zitat Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, McKee A, Tabaton M, Litvan I (1994) Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 44:2015–2019PubMed Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, McKee A, Tabaton M, Litvan I (1994) Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 44:2015–2019PubMed
12.
Zurück zum Zitat Honer WG, Kaufmann CA, Kleinman JE, Casanova MF, Davies P (1989) Monoclonal antibodies to study the brain in schizophrenia. Brain Res 500:379–383CrossRefPubMed Honer WG, Kaufmann CA, Kleinman JE, Casanova MF, Davies P (1989) Monoclonal antibodies to study the brain in schizophrenia. Brain Res 500:379–383CrossRefPubMed
13.
Zurück zum Zitat Horoupian DS, Wisniewski H (1971) Neurofilamentous hyperplasia in inferior olivary hypertrophy. J Neuropathol Exp Neurol 30:571–582PubMed Horoupian DS, Wisniewski H (1971) Neurofilamentous hyperplasia in inferior olivary hypertrophy. J Neuropathol Exp Neurol 30:571–582PubMed
14.
Zurück zum Zitat Jellinger K (1973) Hypertrophy of the inferior olives. Report on 29 cases. Z Neurol 205:153–174PubMed Jellinger K (1973) Hypertrophy of the inferior olives. Report on 29 cases. Z Neurol 205:153–174PubMed
15.
Zurück zum Zitat Kawanami T, Kato T, Llena JF, Hirano A, Sasaki H (1994) Altered synaptophysin-immunoreactive pattern in human olivary hypertrophy. Neurosci Lett 176:178–180PubMed Kawanami T, Kato T, Llena JF, Hirano A, Sasaki H (1994) Altered synaptophysin-immunoreactive pattern in human olivary hypertrophy. Neurosci Lett 176:178–180PubMed
16.
Zurück zum Zitat Koeppen AH, Barron KD, Dentinger MP (1980) Olivary hypertrophy: histochemical demonstration of hydrolytic enzymes. Neurology 30:471–480PubMed Koeppen AH, Barron KD, Dentinger MP (1980) Olivary hypertrophy: histochemical demonstration of hydrolytic enzymes. Neurology 30:471–480PubMed
17.
Zurück zum Zitat Krings T, Foltys H, Meister IG, Reul J (2003) Hypertrophic olivary degeneration following pontine haemorrhage: hypertensive crisis or cavernous haemangioma bleeding? J Neurol Neurosurg Psychiatry 74:797–799CrossRefPubMed Krings T, Foltys H, Meister IG, Reul J (2003) Hypertrophic olivary degeneration following pontine haemorrhage: hypertensive crisis or cavernous haemangioma bleeding? J Neurol Neurosurg Psychiatry 74:797–799CrossRefPubMed
18.
Zurück zum Zitat Lapresle J (1979) Rhythmic palatal myoclonus and the dentato-olivary pathway. J Neurol 220:223–230PubMed Lapresle J (1979) Rhythmic palatal myoclonus and the dentato-olivary pathway. J Neurol 220:223–230PubMed
19.
Zurück zum Zitat Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewki syndrome): report of the NINDS-SPSP international workshop. Neurology 47:1–9PubMed Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewki syndrome): report of the NINDS-SPSP international workshop. Neurology 47:1–9PubMed
20.
Zurück zum Zitat Pierot L, Cervera-Pierot P, Delattre JY, Duyckaerts C, Chiras J, Brunet P (1992) Palatal myoclonus and inferior olivary lesions: MRI-pathologic correlation. J Comput Assist Tomogr 16:160–163PubMed Pierot L, Cervera-Pierot P, Delattre JY, Duyckaerts C, Chiras J, Brunet P (1992) Palatal myoclonus and inferior olivary lesions: MRI-pathologic correlation. J Comput Assist Tomogr 16:160–163PubMed
21.
Zurück zum Zitat Sohn D, Levine S (1971) The hypertrophy of the olives. A report of 43 cases. Prog Neuropathol 3:202–217 Sohn D, Levine S (1971) The hypertrophy of the olives. A report of 43 cases. Prog Neuropathol 3:202–217
22.
Zurück zum Zitat Suyama N, Kobayashi S, Isino H, Iijima M, Imaoka K (1997) Progressive supranuclear palsy with palatal myoclonus. Acta Neuropathol 94:290–293CrossRefPubMed Suyama N, Kobayashi S, Isino H, Iijima M, Imaoka K (1997) Progressive supranuclear palsy with palatal myoclonus. Acta Neuropathol 94:290–293CrossRefPubMed
23.
Zurück zum Zitat Tsuboi Y, Slowinski J, Josephs KA, Honer WG, Wszolek ZK, Dickson DW (2003) Atrophy of superior cerebellar peduncle in progressive supranuclear palsy. Neurology 60:1766–1769PubMed Tsuboi Y, Slowinski J, Josephs KA, Honer WG, Wszolek ZK, Dickson DW (2003) Atrophy of superior cerebellar peduncle in progressive supranuclear palsy. Neurology 60:1766–1769PubMed
24.
Zurück zum Zitat Yagishita S, Itoh Y, Nakano T (1986) Hypertrophy of the olivary nucleus. An ultrastructural study. Acta Neuropathol 69:132–138PubMed Yagishita S, Itoh Y, Nakano T (1986) Hypertrophy of the olivary nucleus. An ultrastructural study. Acta Neuropathol 69:132–138PubMed
Metadaten
Titel
Inferior olivary hypertrophy is uncommon in progressive supranuclear palsy
verfasst von
Omi Katsuse
Dennis W. Dickson
Publikationsdatum
01.08.2004
Verlag
Springer-Verlag
Erschienen in
Acta Neuropathologica / Ausgabe 2/2004
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-004-0878-3

Weitere Artikel der Ausgabe 2/2004

Acta Neuropathologica 2/2004 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

„Restriktion auf vier Wochen Therapie bei Schlaflosigkeit ist absurd!“

06.05.2024 Insomnie Nachrichten

Chronische Insomnie als eigenständiges Krankheitsbild ernst nehmen und adäquat nach dem aktuellen Forschungsstand behandeln: Das forderte der Schlafmediziner Dr. Dieter Kunz von der Berliner Charité beim Praxis Update.

Stuhltransfusion könnte Fortschreiten von Parkinson-Symptomen bremsen

03.05.2024 Parkinson-Krankheit Nachrichten

Kann eine frühzeitige Stuhltransplantation das Fortschreiten von Parkinson-Symptomen verlangsamen? Die Ergebnisse einer randomisierten Phase-2-Studie scheinen dafür zu sprechen.

Frühe Tranexamsäure-Therapie nützt wenig bei Hirnblutungen

02.05.2024 Hirnblutung Nachrichten

Erhalten Personen mit einer spontanen Hirnblutung innerhalb von zwei Stunden nach Symptombeginn eine Tranexamsäure-Therapie, kann dies weder die Hämatomexpansion eindämmen noch die Mortalität senken.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.